U.S. Markets closed

Stocks That Fell to 3-Year Lows in the Week of April 5

- By Shuda Xia

CVS Health Corp. (CVS), Walgreens Boots Alliance Inc. (WBA), Mednax Inc. (MD), and Amdocs Ltd. (DOX) have declined to their three-year lows.

CVS Health Corp. (CVS) declined to $54.06

The prices of CVS Health Corp. (CVS) shares have declined to $54.06 on April 5, which is only 4.2% above the 3-year low of $51.77.


CVS Health Corp. is an American retail pharmacy and health care company that grew from the parent company Mark Steven Inc. The business began as a chain of health and beauty aid stores but within several years pharmacies were added. The company owns several subsidiaries, including CVS Pharmacy, MinuteClinic, Caremark Rx, Longs Drugs, Omnicare, and Navarro Discount Pharmacies.

CVS Health Corp. has a market cap of $70.12 billion; its shares were traded around $54.06 with and P/S ratio of 0.29. The trailing 12-month dividend yield of CVS Health Corp. stocks is 3.70%. The forward dividend yield of CVS Health Corp. stocks is 3.75%. CVS Health Corp. had an annual average earnings growth of 7.40% over the past 10 years.

On April 4 CVS Health Corp. announced that it has completed the rollout of time delay safes in all its 169 pharmacy locations in Tennessee. The safes will help prevent pharmacy robberies to combat the opioid epidemic in the state. These measures will help keep controlled substance narcotic medications out of the possession of unauthorized individuals.

Walgreens Boots Alliance Inc. (WBA) declined to $54.69

The prices of Walgreens Boots Alliance Inc. (WBA) shares have declined to $54.69 on April 5, which is only 1.5% above the 3-year low of $53.85.

Walgreens Boots Alliance Inc. is an American holding company that owns Walgreens, Boots, and other pharmaceutical manufacturing, wholesale, and distribution companies. The company is organized into three divisions: Retail Pharmacy USA, known as Walgreens, Retail Pharmacy International, known as Boots, and Pharmaceutical Wholesale.

Walgreens Boots Alliance Inc. has a market cap of $50 billion; its shares were traded around $54.69 with a P/E ratio of 10.28 and P/S ratio of 0.38. The trailing 12-month dividend yield of Walgreens Boots Alliance Inc. stocks is 3.14%. The forward dividend yield of Walgreens Boots Alliance Inc. stocks is 3.25%. Walgreens Boots Alliance Inc. had an annual average earnings growth of 5.90% over the past 10 years.

On April 2 Walgreens Boots Alliance Inc. reported its second quarter 2019 fiscal results. Sales increased 4.6% to $34.5 billion year-over-year, while operating income decreased 23.3% to $1.5 billion. Adjusted operating income likewise decreased 10.4% to $1.9 billion. Year-over-year earnings per share decreased 8.3% to $1.24, while adjusted earnings per share decreased 5.4% to $1.64.

Mednax Inc. (MD) declined to $28.19

The prices of Mednax Inc. (MD) shares have declined to $28.19 on April 5, which is only 4.3% above the 3-year low of $26.97.

Mednax Inc. is an American specialized health services company that focuses on neonatal, anesthesia, and pediatric physician subspecialty services in all 50 U.S. States and Puerto Rico. The company is the largest provider of newborn hearing screening in the U.S.

Mednax Inc. has a market cap of $2.48 billion; its shares were traded around $28.19 with a P/E ratio of 9.64 and P/S ratio of 0.70. Mednax Inc. had an annual average earnings growth of 9.70% over the past 10 years.

On March 29 Mednax Inc. announced its affiliation with Georgia Neonatology LLC, a private neonatology practice that specializes in neonatal care for pre-term newborns and critically ill babies. Georgia Neonatology has provided healthcare services to Piedmont Healthcare's Piedmont Athens Regional Medical Center since 2013.

Amdocs Ltd. (DOX) declined to $55.21

The prices of Amdocs Ltd. (DOX) shares have declined to $55.21 on April 5, which is only 4.7% above the 3-year low of $52.60.

Amdocs Ltd. is an international communications technology company that focuses on providing software and services for financial services providers and digital enterprises. The company was founded in Israel but is currently headquartered in the United States.

Amdocs Ltd. has a market cap of $7.67 billion; its shares were traded around $55.21 with a P/E ratio of 23.20 and P/S ratio of 1.97. The trailing 12-month dividend yield of Amdocs Ltd. stocks is 1.86%. The forward dividend yield of Amdocs Ltd. stocks is 2.09%. Amdocs Ltd. had an annual average earnings growth of 6.30% over the past 10 years.

On April 4 Amdocs Ltd. announced that Juice Worldwide, a subdivision of the company, has reported that their upgraded Los Angeles post production facility is now open for business. The new facility offers state of the art post production suites and services aimed to expand the company's current offerings.

Disclosure: I do not own stock in any of the companies mentioned in the article.

This article first appeared on GuruFocus.